How Biopharma BD&L Teams are Enhancing Capabilities to Elevate Decision Support
In an effort to bolster pipelines, biopharma manufacturers are reassessing old practices and transforming market research methods.
Insights
So many market access puzzles to solve and so little time. That’s why our agile approach works.
So many market access puzzles to solve and so little time. That’s why our agile approach works.
Will your clinical trials deliver the leverage you need with payers?
Biopharma manufacturers struggle to communicate the clinical value of their medicines to payers for many reasons: payer drug evaluations are...
Biopharma leaders prepare to navigate Medicare’s new negotiating power
The importance of the Medicare market to biopharma’s success in the United States cannot be overstated. The Centers for Medicare and...
A better path to payer insights
Last year, a marketer with two decades of big pharma experience joined one of the healthcare industry’s many emerging biotech...
Because access strategies should be rooted in the truth, not conjecture.
Click below for a brief overview of our game-changing capabilities.
Upgrade your market access game with Formulary Insights today
Leveraging my Cigna experience to help manufacturers improve access for patients is some of the most rewarding work I've done.
A deep understanding of payer interests is paramount, and I’m fortunate to be uniquely qualified to help clients bridge the space with payers to ensure patient access.
Leveraging my experience to generate actionable insights from our panel of active payer decision makers allows me to help clients see the market in entirely new ways.
Understanding market access is one thing; communicating that understanding to payers is quite another. I have a passion for helping clients with both.
Our market access insights can be your strategic advantage